Position in AZN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$151,221,380
+$2,493,637 QoQ
Shares Held
797,497
+5.8% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#108
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $2,652,531,465 across 15 Drug Manufacturers - General names. AZN ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,519,569 | $634,024,342 | |
| 2 | JNJ |
Johnson & Johnson
|
2,173,861 | $552,095,477 | |
| 3 | LLY |
ELI LILLY & Co
|
400,653 | $480,555,266 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,308,510 | $296,643,534 | |
| 5 | NVS |
Novartis AG
|
968,701 | $151,814,820 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
797,497 | $151,221,380 | |
| 7 | AMGN |
Amgen Inc
|
394,190 | $142,744,081 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,277,343 | $73,600,502 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $151,221,380 | 797,497 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $148,727,743 | 754,121 | Shares | Defined | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||